Please login to the form below

Not currently logged in
Email:
Password:

bacterial infections

This page shows the latest bacterial infections news and features for those working in and with pharma, biotech and healthcare.

Basilea moves closer to US filing of novel antibiotic

Basilea moves closer to US filing of novel antibiotic

Analysts expect US launch in 2022. Basilea is halfway towards filing for approval of its broad-spectrum antibiotic ceftobiprole for serious skin infections in the US, after clearing the first of ... Ceftobiprole hit all primary and secondary efficacy

Latest news

More from news
Approximately 2 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Combining therapies and combining research Combining therapies and combining research

    If we can’t defend ourselves from basic bacterial infections, we render other areas of medicine redundant. ... However, antibiotics for common bacterial infections, for example, staphylococci and Escherichia coli continued to be single molecule

  • Another lost decade for research? Another lost decade for research?

    Such technologies, which allow doctors to diagnose bacterial from viral infections or distinguish between different bacteria, could lead to personalised treatments and avoid unnecessary prescription of antibiotics. ... In terms of research focus, the

  • Pharma deals in September 2015 Pharma deals in September 2015

    300. AstraZeneca. US Dept of Health &Human Services. Combining antibiotics to tackle multi-drug resistant bacterial infections.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Licence. 201. GlycoVaxyn/ GSK. Conjugation platform plus early stage vaccines against bacterial infections such as pneumonia, Pseudomonas, S.

  • Curbing the rise of drug resistance Curbing the rise of drug resistance

    The global economic impact of anti-microbial resistance forecasts that, if unchecked, drug-resistant infections could cost the world 10 million extra deaths a year and cost up to $100tn by ... According to Professor Dame Sally Davies, chief medical

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Jennifer Schranz will lead the company’s clinical development business. Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer ... we continue to advance the

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... I am looking forward to working with

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    He said: “Allecra is a dynamic company with the potential to make a significant impact on the growing and widespread epidemic of drug-resistant bacterial infections. ... Hooftman’s new role will see him focus on combating multi drug-resistant

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics